T1	Participants 65 81	HIV-positive men
T2	Participants 238 289	safety and acceptability need to be assessed in men
T3	Participants 434 456	in 36 HIV-positive men
T4	Participants 585 617	were reported in 42% of CS users
T5	Participants 699 723	and 8% of KY Jelly users
T6	Participants 791 819	HIV-positive male population
